HIGH EXPRESSION WITH PD-1+ FOXP3+ ΓΔ T REGULATORY SUBSETS IN CHRONIC MYELOID LEUKEMIA PATIENTS
Sign Up to like & getrecommendations! Published in 2019 at "Experimental Hematology"
DOI: 10.1016/j.exphem.2019.06.462
Abstract: Objective Tyrosine kinase inhibitor (TKI) has achieved certain efficacy in treatment of chronic myeloid leukemia (CML), but there are still many cases of drug resistance and relapse. Anti-leukemia immunity of γδ T cells may play… read more here.
Keywords: expression; leukemia; cml patients; regulatory subsets ... See more keywords